Wells Fargo & Company MN Cuts Stock Position in Avidity Biosciences, Inc. (NASDAQ:RNA)

Wells Fargo & Company MN decreased its position in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 1.6% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 172,570 shares of the biotechnology company’s stock after selling 2,771 shares during the quarter. Wells Fargo & Company MN’s holdings in Avidity Biosciences were worth $5,018,000 at […]